Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

May 31, 2006

Conditions
Chronic Neuropathic Pain
Interventions
DRUG

ORAVESCENT Fentanyl Citrate

Trial Locations (17)

27401

PharmQuest, Greensboro

30060

Center for Prospective Outcome, Marietta

Georgia Medical Research, Marietta

32207

Florida Institute of Medical R, Jacksonville

33331

Gold Coast Research, Weston

33617

Clinical Pharmacology Services, Tampa

33765

Clinical Research of W Florida, Clearwater

46383

American Medical Research, Valparaiso

50265

Iowa Pain Management Clinic, P, Des Moines

60523

American Medical Research, Oak Brook

60616

American Medical Research, Chicago

66211

Mid America Physiatrists, PA, Overland Park

70115

Best Clinical Trial, Inc., New Orleans

72401

Clopton Clinic, Jonesboro

92106

San Diego Arthritis Medical, San Diego

93311

Vertex Clinical Research, Inc., Bakersfield

98004

Northwest Clinical Research, Bellevue

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00214955 - Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain | Biotech Hunter | Biotech Hunter